×
About 1,605 results

ALLMedicine™ Genital Warts Center

Research & Reviews  467 results

The Annual costs of treating genital warts in the Public Healthcare Sector in Peru.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518193
BMC Health Services Research; Saldarriaga EM, Cárcamo CP et. al.

Oct 16th, 2021 - To estimate the cost of six different techniques used to treat Genital Warts and the annual average cost of treating a typical GW patient in Peru. To estimate the annual economic burden diagnosing and treating GW in the Peruvian public healthcare ...

Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis under...
https://doi.org/10.1684/ejd.2021.4121
European Journal of Dermatology : EJD; Offidani A, Radi G et. al.

Oct 14th, 2021 - Psoriasis is an immune-mediated inflammatory disease and its relationship with infection has been extensively investigated. Concern for the increased prevalence of human papilloma virus (HPV) infection in patients undergoing systemic immunomodulat...

Evaluating Risk-Stratified HPV Catch-up Vaccination Strategies: Should We Go beyond Age...
https://doi.org/10.1177/0272989X211042894
Medical Decision Making : an International Journal of The... Wang F, Jozkowski KN et. al.

Oct 13th, 2021 - Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. HPV can cause genital warts and multiple types of cancers in females. HPV vaccination is recommended to youth age 11 or 12 years before sexual initi...

Evidence-Based Practice Model to Increase Human Papillomavirus Vaccine Uptake: A Stepwi...
https://doi.org/10.1016/j.nwh.2021.09.006
Nursing for Women's Health; Beck A, Bianchi A et. al.

Oct 12th, 2021 - To increase uptake of human papillomavirus (HPV) vaccination by implementing a stepwise evidence-based practice model to offer HPV education along with a strong provider recommendation to parents of youth and adolescents. Evidence-based practice c...

Assessing Durable Antibody Response to HPV Vaccination
https://clinicaltrials.gov/ct2/show/NCT05031078

Oct 8th, 2021 - Human papillomaviruses (HPV) cause cervical, anal, oropharyngeal, vulvar, vaginal, and penile cancers. There are over 200 types of HPV; 12 are known to cause cancer. The current HPV vaccine is a subunit vaccine, meaning it is made of only part of ...

see more →

Guidelines  5 results

Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
https://doi.org/10.1097/AOG.0000000000004000
Obstetrics and Gynecology;

Aug 1st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Committee Opinion No. 704 Summary: Human Papillomavirus Vaccination.
https://doi.org/10.1097/AOG.0000000000002111
Obstetrics and Gynecology;

May 26th, 2017 - Human papillomavirus (HPV) is associated with anogenital cancer (including cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts. The HPV vaccination significantly reduces the incidence of anogenital cancer and geni...

Committee Opinion No. 704: Human Papillomavirus Vaccination.
https://doi.org/10.1097/AOG.0000000000002052
Obstetrics and Gynecology;

Mar 28th, 2017 - Human papillomavirus (HPV) is associated with anogenital cancer (including cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts. The HPV vaccination significantly reduces the incidence of anogenital cancer and geni...

Sexually transmitted diseases treatment guidelines, 2015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885289
MMWR. Recommendations and Reports : Morbidity and Mortali... Workowski KA, Bolan GA et. al.

Jun 5th, 2015 - These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30-M...

Committee opinion no. 588: human papillomavirus vaccination.
https://doi.org/10.1097/01.AOG.0000444458.00612.6b
Obstetrics and Gynecology;

Feb 21st, 2014 - The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that human papillomavirus (HPV) vaccination routinely be targeted to females and males aged 11 years or 12 years as part of the adolescen...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  15 results

Assessing Durable Antibody Response to HPV Vaccination
https://clinicaltrials.gov/ct2/show/NCT05031078

Oct 8th, 2021 - Human papillomaviruses (HPV) cause cervical, anal, oropharyngeal, vulvar, vaginal, and penile cancers. There are over 200 types of HPV; 12 are known to cause cancer. The current HPV vaccine is a subunit vaccine, meaning it is made of only part of ...

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
https://clinicaltrials.gov/ct2/show/NCT02119702

Aug 26th, 2021 - AMP Up aims to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition into adulthood. A group of perinatally HIV-exposed, -uninfected (PHEU) young adults from a similar s...

CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
https://clinicaltrials.gov/ct2/show/NCT04738734

Jun 3rd, 2021 - The study will enroll healthy adult subjects with a minimum of two cutaneous non-genital warts, excluding the face, with each wart lesion not exceeding 10 x 10mm. Macrophotography of all study warts will be captured along with a blinded site Inves...

High and Low Resource Interventions to Promote HPV Vaccines
https://clinicaltrials.gov/ct2/show/NCT03824093

Jan 20th, 2021 - Significance: Human Papillomavirus (HPV) is the most common sexually transmitted infection in the United States with an estimated 14 million new infections each year. While most HPV infections resolve without any symptoms or signs of infection, so...

Efficacy and Tolerability of Topical LFX453 for External Genital Warts
https://clinicaltrials.gov/ct2/show/NCT02482428

Jan 5th, 2021 - The LFX453X2202 study tested the investigational drug LFX453 against placebo for safety, tolerability, and efficacy in treating genital warts in circumcised men, in parallel with an additional open label arm using imiquimod 5%. During the study th...

see more →

News  142 results

HPV Vaccination Rates Continue to Climb Among Young Adults in US
https://www.medscape.com/viewarticle/950043

Apr 27th, 2021 - Although vaccination rates against the human papillomavirus (HPV) remain low for young adults across the United States, the number of self-reported HPV vaccinations among women and men between the ages of 18 and 21 years has markedly increased sin...

2021 Update on gynecologic cancer
https://www.mdedge.com/obgyn/article/237049/gynecologic-cancer
Shayan Dioun, MD, Jason D. Wright, MD

Mar 10th, 2021 - Gynecologic malignancies continue to be a major cause of cancer-related mortality in women. In 2020, a number of developments changed practice in gynecologic oncology.

HPV and the Rise of Head and Neck Cancers
https://www.onclive.com/view/hpv-and-the-rise-of-head-and-neck-cancers

Dec 5th, 2020 - Human papillomavirus is perhaps best known as the main cause of cervical cancer, but if recent trends continue, by 2020 HPV will cause more cases of oropharyngeal cancer each year than cervical cancer. Changes in public perceptions of the virus, a...

FDA Approves Gardasil 9 HPV Vaccine for Use Up to Age 45
https://www.onclive.com/view/fda-approves-gardasil-9-hpv-vaccine-for-use-up-to-age-45

Dec 4th, 2020 - The HPV vaccine Gardasil 9 (HPV 9-valent Vaccine, Recombinant) is now approved by the FDA for use in males and females aged 9 through 45 years.1 Gardasil 9 has been shown to prevent cancers and other diseases caused by the 9 types of HPV: 6, 11, ...

HPV Vaccine Shown to Substantially Reduce Cervical Cancer Risk
https://www.medscape.com/viewarticle/938393

Oct 1st, 2020 - Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial reduction in the incidence of cervical cancer in a Swedish review of more than 1 million girls and women vaccinated from 2006–2017. It's been shown that the vacc...

see more →

Patient Education  6 results see all →